Clin Psychopharmacol Neurosci.  2019 Feb;17(1):134-138. 10.9758/cpn.2019.17.1.134.

A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine

Affiliations
  • 1Department of Psychiatry, Faculty of Medicine, Namık Kemal University, Tekirdag, Turkey. dr.fuge@hotmail.com

Abstract

Rabbit Syndrome is an uncommon side effect of antipsychotic treatment. Although it is usually associated with typical antipsychotics, it can also be related to atypical antipsychotics. Anticholinergics are the most accepted treatment approach in treating Rabbit Syndrome. Fluvoxamine is a member of selective serotonin reuptake inhibitors and it is a potent agonist of sigma 1 receptors. In this article, we report a Rabbit Syndrome case who has benefited from fluvoxamine, in terms of both depressive disorder and Rabbit Syndrome; and present the data on the effects of sigma 1 agonist fluvoxamine on numerous movement disorders.

Keyword

Rabbit syndrome; Sigma receptors; Side effect; Fluvoxamine

MeSH Terms

Antipsychotic Agents
Cholinergic Antagonists
Depressive Disorder
Fluvoxamine*
Movement Disorders
Receptors, sigma
Serotonin Uptake Inhibitors
Antipsychotic Agents
Cholinergic Antagonists
Fluvoxamine
Receptors, sigma
Serotonin Uptake Inhibitors
Full Text Links
  • CPN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error